Market Place
Sourcing Support
Hainan Poly`s Generics Cisatracurium Besylate Receives Approval in US
27 Aug 2024 //
FDA
Hainan Poly`s Generic Cisatracurium Besylate Receives Approval in the U.S.
08 Mar 2024 //
FDA
Caplin`s Generic Cisatracurium Besylate Receives Approval in the U.S.
09 Jun 2023 //
FDA
Development Of Manufacturing Technology For Three Pharmaceutical Ingredients
30 Jan 2023 //
PRESS RELEASE
Piramal`s Generic Cisatracurium Besylate Receives Approval in the U.S.
11 Mar 2022 //
FDA
Enforcement Report - Week of March 3, 2021
03 Mar 2021 //
FDA
Zydus Cadila gets US FDA approval for Cisatracurium Besylate Injection
02 Sep 2020 //
EXPRESSPHARMA
Zydus Cadila receives US FDA approval to market cisatracurium besylate injection
01 Sep 2020 //
PHARMABIZ
Piramal Healthcare Generic`s Cisatracurium Besylate Reveives Approval in US
06 May 2020 //
FDA
Boots consultation rooms to become ‘safe spaces’ for patients
01 May 2020 //
PHARMACEUTICAL-JOURNAL
Wavelength Expands Supplies of Key Drug Ingredients for Critically Ill COVID-19
20 Apr 2020 //
BIOSPACE
Wavelength Ups API Production for Essential Respiratory Meds
20 Apr 2020 //
CONTRACTPHARMA
CORRECTING & REPLACING Vizient Applauds FDA’s Temporary Policy Compounding
17 Apr 2020 //
BUSINESSWIRE
Accord Healthcare addresses shortages critical ventilator medicines for COVID-19
17 Apr 2020 //
ACCORD-HEALTHCARE
Zydus Pharms USA`s Generic Ramelteon Receives Approval in US
07 Nov 2019 //
FDA
Zydus Cadila gets US FDA approval for generic muscle relaxing injection
05 Nov 2019 //
BUSINESS-STANDARD
CF Pharma received HALAL certification
06 Jul 2019 //
PRESS RELEASE
Nanjing King-Friend`s Generic Cisatracurium Besylate Receives Approval in US
30 Apr 2019 //
FDA
Somerset Theraps` Generic Cisatracurium besylate Receives Approval in US
23 Feb 2019 //
FDA
Pfizer demands return of drugs set for use in US lethal injections
22 Nov 2017 //
IN PHARMATECHNOLOGY
Jiangsu Hengrui Med’s Generic Cisatracurium Besylate Receives Approval In US
01 Sep 2017 //
FDA
Accord Hlthcare’s Generic Cisatracurium Besylate Receives Approval In US
20 Jun 2017 //
FDA
Jiangsu Hengrui`s Generic Cisatracurium Besylate Receives Approval In US
27 Jan 2017 //
FDA
Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.
02 May 2015 //
FIERCE PHARMA MFG
Japan MHLW panel names 11 unapproved/off-label drugs for fast-track reviews
28 Apr 2015 //
FIERCE PHARMA ASIA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.